Anteris Technologies Global (NASDAQ:AVR) Earns Overweight Rating from Analysts at Wells Fargo & Company

Wells Fargo & Company started coverage on shares of Anteris Technologies Global (NASDAQ:AVR) in a research report released on Wednesday, MarketBeat.com reports. The brokerage issued an overweight rating and a $16.00 price objective on the stock.

Several other brokerages also recently commented on AVR. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Anteris Technologies Global in a research note on Monday, December 29th. Lake Street Capital restated a “buy” rating and issued a $15.00 price target on shares of Anteris Technologies Global in a report on Friday, January 23rd. Finally, Cantor Fitzgerald upgraded Anteris Technologies Global to a “strong-buy” rating in a report on Wednesday, March 4th. Three analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $15.33.

Anteris Technologies Global Stock Down 5.9%

Shares of NASDAQ:AVR opened at $6.19 on Wednesday. The company has a 50 day moving average price of $5.78 and a two-hundred day moving average price of $5.01. The company has a debt-to-equity ratio of 0.01, a quick ratio of 0.73 and a current ratio of 0.73. The company has a market capitalization of $255.02 million, a PE ratio of -2.42 and a beta of 1.15. Anteris Technologies Global has a 52 week low of $2.34 and a 52 week high of $7.09.

Anteris Technologies Global (NASDAQ:AVR) last announced its quarterly earnings results on Thursday, February 26th. The company reported ($0.75) earnings per share for the quarter. Anteris Technologies Global had a negative return on equity of 536.04% and a negative net margin of 4,921.27%.The firm had revenue of $0.31 million for the quarter. Analysts forecast that Anteris Technologies Global will post -2.66 earnings per share for the current year.

Insider Buying and Selling at Anteris Technologies Global

In related news, major shareholder L1 Capital Pty Ltd acquired 5,000,000 shares of the stock in a transaction dated Thursday, January 22nd. The stock was bought at an average price of $5.75 per share, with a total value of $28,750,000.00. Following the completion of the transaction, the insider directly owned 13,219,814 shares of the company’s stock, valued at approximately $76,013,930.50. The trade was a 60.83% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 4.50% of the stock is owned by company insiders.

Institutional Investors Weigh In On Anteris Technologies Global

Institutional investors have recently added to or reduced their stakes in the stock. Marex Group plc bought a new position in Anteris Technologies Global during the 2nd quarter worth about $641,000. Intech Investment Management LLC acquired a new stake in shares of Anteris Technologies Global in the 2nd quarter valued at about $49,000. Bridgeway Capital Management LLC bought a new stake in shares of Anteris Technologies Global in the fourth quarter valued at about $175,000. Macquarie Group Ltd. lifted its holdings in shares of Anteris Technologies Global by 12,369.6% in the fourth quarter. Macquarie Group Ltd. now owns 33,668 shares of the company’s stock valued at $168,000 after purchasing an additional 33,398 shares in the last quarter. Finally, Walleye Capital LLC acquired a new position in shares of Anteris Technologies Global during the fourth quarter worth about $147,000.

Anteris Technologies Global Company Profile

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.